Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species
文献类型:期刊论文
作者 | Li, Mingyue1,2; Song, Li-Hua3; Yue, Grace Gar-Lee2,4; Lee, Julia Kin-Ming2,4; Zhao, Li-Mei5; Li, Lin6; Zhou, Xunian1,2; Tsui, Stephen Kwok-Wing1; Ng, Simon Siu-Man6; Fung, Kwok-Pui1,2,4 |
刊名 | SCIENTIFIC REPORTS
![]() |
出版日期 | 2017-02-09 |
卷号 | 7期号:0页码:42176 |
英文摘要 | Colorectal cancer (CRC) is the third most prevalent cancer and the third highest cancer-related mortality in the United States. Bigelovin, a sesquiterpene lactone isolated from Inula helianthus aquatica, has been proven to induce apoptosis and exhibit anti-inflammatory and anti-angiogenic activities. However, the effects of bigelovin on CRC and underlying mechanisms have not been explored. The present study demonstrated that bigelovin exhibited potent anti-tumor activities against CRC in vitro and in vivo. Bigelovin suppressed cell proliferation and colony formation and induced apoptosis in human colorectal cancer HT-29 and HCT 116 cells in vitro. Results also revealed that bigelovin activated caspases, caused the G2/M cell cycle arrest and induced DNA damage through up-regulation of death receptor (DR) 5 and increase of ROS. In HCT 116 xenograft model, bigelovin treatment resulted in suppression of tumor growth. Bigelovin at 20 mg/kg showed more significant tumor suppression and less side effects than conventional FOLFOX (containing folinic acid, 5-fluorouracil and oxaliplatin) treatment. In addition, in vivo data confirmed that anti-tumor activity of bigelovin in CRC was through induction of apoptosis by up-regulating DR5 and increasing ROS. In conclusion, these results strongly suggested that bigelovin has potential to be developed as therapeutic agent for CRC patients. |
类目[WOS] | Multidisciplinary Sciences |
研究领域[WOS] | Science & Technology - Other Topics |
关键词[WOS] | CELL-CYCLE ARREST ; PANCREATIC ADENOCARCINOMA CELLS ; INULA-HELIANTHUS-AQUATICA ; TRAIL-INDUCED APOPTOSIS ; COLON-CANCER ; DNA-DAMAGE ; TUMOR-CELLS ; PROLIFERATION ; PATHWAYS ; GROWTH |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000393834100001 |
源URL | [http://ir.kib.ac.cn/handle/151853/41891] ![]() |
专题 | 昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | 1.Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China 2.Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China 3.China Pharmaceut Univ, Sch Tradit Chinese Med, Nanjing 211198, Jiangsu, Peoples R China 4.Chinese Univ Hong Kong, State Key Lab Phytochem & Plant Resources West Ch, Shatin, Hong Kong, Peoples R China 5.Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming 650201, Peoples R China 6.Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Mingyue,Song, Li-Hua,Yue, Grace Gar-Lee,et al. Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species[J]. SCIENTIFIC REPORTS,2017,7(0):42176. |
APA | Li, Mingyue.,Song, Li-Hua.,Yue, Grace Gar-Lee.,Lee, Julia Kin-Ming.,Zhao, Li-Mei.,...&Lau, Clara Bik-San.(2017).Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species.SCIENTIFIC REPORTS,7(0),42176. |
MLA | Li, Mingyue,et al."Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species".SCIENTIFIC REPORTS 7.0(2017):42176. |
入库方式: OAI收割
来源:昆明植物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。